<?xml version="1.0" encoding="UTF-8"?>
<p>Until the introduction of new anti-HCV drugs, some authors suggested that all kidney transplant candidates should undergo antiviral treatment before receiving a kidney transplant [
 <xref rid="B18" ref-type="bibr">18</xref>]. As high efficiency therapy started to be used in our patients, we decided to review the evolution of HCV patients prior to availability of these drugs. We therefore conducted a retrospective study to determine the follow-up of kidney transplant recipients in our center.
</p>
